neuroimaging
The Neuroimaging group explores the determinants of cognitive health in aging-related pathologies.
activities
Magali Perquin is currently PI at the Department of Precision Health of the Luxembourg Institute of Health. First involved in (molecular) epidemiology, throughout her career she has been responsible for health surveys on chronic diseases (including diabetes and osteoporosis), but also for the implementation of population-based research studies (MemoVie, Memolingua). Her main scientific interest is now to study the processes of cognitive decline in normal and pathological aging, exploring the determinants of cognitive health. She also focuses on explaining observed outcomes using neuroimaging strategies in an exploratory approach that aims to expand the possibilities of neuroepidemiology.
WATCH 📺
Contribution of neuroimaging to personalised Precision Health strategies
Perquin
Projects & clinical trials
Featured team members
Scientific publications
-
Long COVID cognitive sequelae 6 months postinfection and beyond – 06/06/2024
-
Population ageing and public finance burden of dementia – 18/05/2024
-
Converging peripheral blood microRNA profiles in Parkinson’s disease and progressive supranuclear palsy – 31/05/2024
-
Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism – 19/03/2024
-
Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE) – 09/02/2024
-
Long COVID Cognitive Sequelae 6 Months Post Infection and Beyond: A Scoping Review Protocol – 09/01/2024
-
Education as Risk Factor of Mild Cognitive Impairment – 01/01/2024
-
Luxembourg Parkinson’s study -comprehensive baseline analysis of Parkinson’s disease and atypical parkinsonism – 19/12/2023
-
Author Correction – 18/12/2023
-
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study – 23/11/2023